Applications of manganese-enhanced magnetic resonance imaging (MEMRI) to imaging of the heart

NMR in Biomedicine

Volumn 17, Issue 8, 2004, Pages 581-594

  Wendland, Michael F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Contrast media; Magnetic resonance imaging; Manganese; Myocardial function; Myocardial ischemia; Myocardial perfusion

Indexed keywords

CALCIUM; CARDIOLOGY; CELLS; CHELATION; HEART VALVE PROSTHESES; MANGANESE COMPOUNDS; POSITIVE IONS; SALTS; TOXICITY;

CARDIAC MRI; CARDIOTOXICITY; CHELATES; MANGANESE-ENHANCED MAGNETIC RESONANCE IMAGING (MEMRI);

MAGNETIC RESONANCE IMAGING;

CALCIUM CHANNEL; CALCIUM ION; CHELATE; DIPYRIDAMOLE; EVP 1001 1; GADOLINIUM; GADOLINIUM PENTETATE ALBUMIN; GADOVERSETAMIDE; MANGAFODIPIR; MANGANESE; MANGANESE CHLORIDE; MANGANESE DERIVATIVE; MANGANESE ETHYLENEDIAMINE TETRAPHOSPHONATE; MANGANESE GLUCONATE; METAL CHELATE; MP 2269; MP 680; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; UNCLASSIFIED DRUG;

BINDING COMPETITION; BLOOD LEVEL; CARDIOTOXICITY; CHELATION THERAPY; CONTRAST ENHANCEMENT; DRUG ACCUMULATION; DRUG COMPETITION; DRUG HALF LIFE; DRUG RETENTION; DRUG UPTAKE; HEART DISEASE; HEART FUNCTION; HEART MUSCLE CELL; HUMAN; MAGNET; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIOCARDIOGRAPHY; REVIEW;

ANIMALS; CONTRAST MEDIA; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MANGANESE; MYOCARDIAL ISCHEMIA; MYOCARDIUM; VENTRICULAR DYSFUNCTION, LEFT;

EID: 12344317091     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/nbm.943     Document Type: Review

References (83)

1. Lauterbur PC, Dias MHM, Rudin AM. Augmentation of tissue water proton spin-lattice relaxation rates by in vivo addition of paramagnetic ions. In Frontiers of Biological Energetics, Dutton PL, Leigh JS, Scarpa A (eds). Academic Press: New York, 1978; 752-759.
2. Mendonca-Dias MH, Gaggelli E, Lauterbur PC. Paramagnetic contrast agents in nuclear magnetic resonance medical imaging. Sem. Nucl. Med. 1983; 13: 364-376.
3. Spanier AM, Weglicki WB, Stiers DL, Misra HP. Superoxide dismutase: tissue, cellular, and subcellular distribution in adult canine heart. Am. J. Physiol. 1985; 249: C379-C384.
4. Brady TJ, Goldman MR, Pykett IL, Buonanno FS, Kistler JP, Newhouse JH, Burt CT, Hinshaw WS, Pohost GM. Proton nuclear magnetic resonance imaging of regionally ischemic canine hearts: effect of paramagnetic proton signal enhancement. Radiology 1982; 144: 343-347.
5. Goldman MR, Brady TJ, Pykett IL, Burt CT, Buonanno FS, Kistler JP, Newhouse JH, Hinshaw WS, Pohost GM. Quantification of experimental myocardial infarction using nuclear magnetic resonance imaging and paramagnetic ion contrast enhancement in excised canine hearts. Circulation 1982; 66: 1012-1016.
6. 1 response to manganese injection in the dog and rabbit. Am. J. Roentgenol. 1983; 141: 193-197.
7. Pflugfelder PW, Wendland MF, Holt WW, Quay SC, Worah D, Derugin N, Higgins CB. Acute myocardial ischemia: MR imaging with Mn-TP. Radiology 1988; 167: 129-133.
8. Pomeroy OH, Wendland M, Wagner S, Derligin N, Holt WW, Rocklage SM, Quay S, Higgins CB. Magnetic resonance imaging of acute myocardial ischemia using a manganese chelate, Mn-DPDP. Invest. Radiol. 1989; 24: 531-536.
9. Saeed M, Wagner S, Wendland ME, Derugin N, Finkbeiner WE, Higgins CB. Occlusive and reperfused myocardial infarcts: differentiation with Mn-DPDP-enharced MR imaging. Radiology 1989; 172:59-64.
10. Saeed M, Wendland MF, Takehara Y, Higgins CB. Reversible and irreversible injury in the reperfused myocardium: differentiation with contrast material-enhanced MR imaging. Radiology 1990; 175: 633-637.
11. Schaefer S, Lange RA, Kulkarni PV, Katz J, Parkey RW, Willerson JT, Peshock RM. In vivo nuclear magnetic resonance imaging of myocardial perfusion using the paramagnetic contrast agent manganese gluconate. J. Am. Coll. Cardiol. 1989; 14: 472-480.
12. Schaefer S, Lange RA, Gutekunst DP, Parkey RW, Willerson JT, Peshock RM. Contrast-enhanced magnetic resonance imaging of hypoperfused myocardium. Invest. Radiol. 1991; 26: 551-556.
13. Hunter DR, Haworth RA, Berkoff HA. Cellular manganese uptake by the isolated perfused rat heart: a probe for the sarcolemma calcium channel. J. Mol. Cell. Cardiol. 1981; 13: 823-832.
14. Mauss Y, Grucker D, Fornasiero D, Chambron J. NMR compartmentalization of free water in the perfused rat heart. Magn. Reson. Med. 1985; 2: 87-194.
15. Brurok H, Schojjt J, Berg K, Karlsson JO, Jynge P. Effects of manganese dipyridoxyl diphosphate, dipyridoxyl diphosphate, and manganese chloride on cardiac function: an experimental study in the Langendorff perfused rat heart. Invest. Radiol. 1995; 30: 159-167.
16. Brurok H, Schjott J, Berg K, Karlsson JO, Jynge P. Manganese and the heart: acute cardiodepression and myocardial accumulation of manganese. Acta Physiol. Scand. 1997; 159: 33-40.
17. 2 on cardiac energy metabolism and manganese accumulation: an experimental study in the isolated perfused rat heart. Invest. Radiol. 1997; 32: 205-211.
18. Brurok H, Skoglund T, Berg K, Skarra S, Karlsson JO, Jynge P. Myocardial manganese elevation and proton relaxivity enhancement with manganese dipyridoxyl diphosphate: Ex vivo assessments in normally perfused and ischemic guinea pig hearts. NMR Biomed. 1999; 12 364-372.
19. Brurok H, Berg K, Sneen L, Grant D, Karlsson JO, Jynge P. Cardiac metal contents after infusions of manganese: an experimental evaluation in the isolated rat heart. Invest. Radiol. 1999; 34 470-476.
20. Saeed M, Higgins CB, Geschwind JF, Wendland MF. T 1-relaxation kinetics of extracellular, intracellular and intravascular MR contrast agents in normal and acutely reperfused infarcted myocardium using echo-planar MR imaging. Eur. Radiol. 2000; 10: 310-318.
21. Bremerich J, Saeed M, Arheden H, Higgins CB, Wendland MF. Normal and infarcted myocardium: differentiation with cellular uptake of manganese at MR imaging in a rat model. Radiology 2000; 216: 524-530.
22. Flacke S, Allen JS, Chia JM, Wible JH, Periasamy MP, Adams MD, Adzamli IK, Lorenz CH. Characterization of viable and nonviable myocardium at MR imaging: comparison of gadolinium-based extracellular and blood pool contrast materials versus manganese-based contrast materials in a rat myocardial infarction model. Radiology 2003; 226: 731-738.
23. Hu TC, Pautler RG, MacGowan GA, Koretsky AP. Manganese-enhanced MRI of mouse heart during changes in inotropy. Magn. Reson. Med. 2001; 46: 884-890.
24. 2 in rats. Radiology 2004; 230: 183-190.
25. Storey P, Danias PG, Post M, Li W, Seoane PR, Harnish PP, Edelman RR, Prasad PV. Preliminary evaluation of EVP 1001-1: a new cardiac-specific magnetic resonance contrast agent with kinetics suitable for steady-state imaging of the ischemic heart. Invest. Radiol. 2003; 38: 642-652.
26. 2. Acta Radiol. 1997; 38:740-749.
27. Brurok H, Ardenkjaer-Larsen JH, Hansson G, Skarra S, Berg K, Karlsson JO, Laursen I, Jynge P. Manganese dipyridoxyl diphosphate: MRI contrast agent with antioxidative and cardioprotective properties? Biochem. Biophys. Res. Commun. 1999; 254: 768-772.
28. Karlsson JO, Brurok H, Eriksen M, Towart R, Toft KG, Moen O, Engebretsen B, Jynge P, Refsum H. Cardioprotective effects of the MR contrast agent MnDPDP and its metabolite MnPLED upon reperfusion of the ischemic porcine myocardium. Acta Radiol. 2001; 42: 540-547.
29. 2 in dogs with acute ischaemic heart failure. Acta Radiol. 1997; 38: 750-758.
30. Scriven DRL, Dan P, Moore EDW. Distribution of proteins implicated in excitation-contraction coupling in rat ventricular myocytes. Biophys. J. 2000; 79: 2682-2691.
31. Bers DM, Perez-Reyes E. Ca channels in cardiac myocytes: structure and function in Ca influx and intracellular Ca release. Cardiovasc. Res. 1999; 42: 339-360.
32. Carmeliet E. Cardiac ionic currents and acute ischemia: from channels to arrhythmias. Physiol. Rev. 1999; 79: 917-1017.
33. Lehmann-Horn F, Jurkat-Rott K. Voltage-gated ion channels and hereditary disease. Physiol. Rev. 1999; 79: 1317-1372.
34. Bers DM. Calcium fluxes involved in control of cardiac myocyte contraction. Circul. Res. 2000; 87: 275-281.
35. Roden DM, Balser JR, George AL, Anderson ME. Cardiac ion channels. A. Rev. Physiol. 2002; 64: 431-475.
36. Maier LM, Bers DM, Calcium, calmodulin, and calcium-calmoculin kinase II: heartbeat to heartbeat and beyond. J. Mol. Cell. Cardiol. 2002; 34: 919-939.
37. Gordon AM, Homsher E, Regnier M. Regulation of contraction in striated muscle. Physiol. Rev. 2000; 80: 853-924.
38. Wuytack F, Raeymaekers L, Missiaen L. Molecular physiology of the SERCA and SPCA pumps. Cell Calcium 2002; 32: 279-305.
39. Blaustein MP, Lederer WJ. Sodium/calcium exchange: its physiological implications. Physiol. Rev. 1999; 79: 763-854.
40. Philipson KD, Nicoll DA. Sodium-calcium exchange: a molecular perspective. A. Rev. Physiol. 2000; 62: 111-133.
41. Bernardi P. Mitochondrial transport of cations: channels, exchangers, and permeability transition. Physiol. Rev. 1999; 79 1127-1155.
42. Ochi R. The slow inward current and the action of manganese ions in guinea-pig's myocardium. Pflug. Arch. 1970; 316: 81-94.
43. Ochi R. Manganese-dependent propagated action potentials and their depression by electrical stimulation in guinea-pig myocardium perfused by sodium-free media. J. Physiol. 1976; 263: 139-156.
44. Chapman RA, Ellis D. Uptake and loss of manganese from perfused frog ventricles. J. Physiol. 1977; 272: 355-366.
45. Haworth RA, Goknur AB, Berkoff HA. Measurement of Ca channel activity of isolated adult rat heart cells using 54Mn. Arch. Biochem. Biophys. 1989; 268: 594-604.
46. 2 and MnDPDP on the isolated and perfused rat heart. Invest. Radiol. 1997; 32: 581-588.
47. Sather WA, McCleskey EW. Permeation and selectivity in calcium channels. A. Rev. Physiol. 2003; 65: 133-159.
48. Atkins HL, Som P, Fairchild RG, Hui J, Schachner E, Goldman A, Ku T. Myocardial positron tomography with manganese-52m. Radiology 1979; 133: 769-774.
49. Chauncey DM Jr, Schelbert HR, Halpern SE, Delano F, McKegney ML, Ashburn WL, Hagan PL. Tissue distribution studies with radioactive manganese: a potential agent for myocardial imaging. J. Nucl. Med. 1977; 18: 933-936.
50. Maynard LS, Cotzias GC. The partition of manganese among organs and intracellular organelles of the rat. J. Biol. Chem. 1955; 214: 489-495.
51. 2+ exchange in bullfrog ventricle. Am. J. Physiol. 1987; 253: C45-C51.
52. 2+ on neonatal and adult rat heart: initial depression and late augmentation of contractile force. Eur. J. Pharmac. 1992; 222: 223-226.
53. Tanaka H, Ishii T, Fujisaki R, Miyamoto Y, Tanaka Y, Aikawa T, Hirayama W, Kawanishi T, Shigenobu K. Effect of Manganese on guinea pig ventricle: initial depression and late augmentation of contractile force. Biol. Pharm. Bull. 2002; 25: 323-326.
54. 2+ fluxes in mitochondria of the perfused rat heart. Circul. Res. 1980; 47: 721-727.
55. Gavin CE, Gunter KK, Gunter TE. Manganese and calcium transport in mitochondria: implications for manganese toxicity. Neurotoxicology 1999; 20: 445-453.
56. Gunter TE, Miller LM, Gavin CE, Eliseev R, Salter J, Buntinas L, Alexandrov A, Hammond S, Gunter KK. Determination of the oxidation states of manganese in brain, liver, and heart mitochondria. J. Neurochem. 2004; 88: 266-280.
57. Kang YS, Gore JC. Studies of tissue NMR relaxation enhancement by manganese: dose and time dependences. Invest. Radiol. 1984; 19: 399-407.
58. Nordhøy W, Anthonsen HW, Bruvold M, Jynge P, Krane J, Brurok H. Manganese ions as intracellular contrast agents: proton relaxation and calcium interactions in rat myocardium. NMR Biomed. 2003; 16: 82-95.
59. Scholz TD. Reduction in myocardial high energy phosphate spin lattice relaxation times using manganese. NMR Biomed. 1994; 7 137-140.
60. Barnhart JL, Berk RN, Andre M. Influence of Mn(II) on NMR relaxation times of biological fluids. Physiol. Chem. Phys. Med. NMR 1985; 17: 53-60.
61. Barnhart JL, Berk RN. Influence of paramagnetic ions and pH on proton NMR relaxation of biologic fluids. Invest. Radiol. 1986; 21: 132-136.
62. Buck A, Nguyen N, Burger C, Ziegler S, Frey L, Weigand G, Erhardt W, Senekowitsch-Schmidtke R, Pellikka R, Blauenstein P, Locher JT, Schwaiger M. Quantitative evaluation of manganese-52m as a myocardial perfusion tracer in pigs using positron emission tomography. Eur J. Nucl. Med. 1996; 23: 1619-1627.
63. Rocklage SM, Cacheris WP, Quay SC, Hahn FE, Raymond KN. Manganese (II) N,N′ -dipyridoxylethylenediamine-N, N′-diacetate 5,5′-bis(phosphate): synthesis and characterization of a paramagnetic chelate for magnetic resonance imaging enhancement. Inorg. Chem. 1989; 28: 477-485.
64. Toft KG, Kindberg GM, Skotland T. Mangafodipir trisodium injection, a new contrast medium for magnetic resonance imaging: in vitro metabolism and protein binding studies of the active component MnDPDP in human blood. J. Pharm. Biomed. Anal. 1997; 15: 983-988.
65. Toft KG, Hustvedt SO, Grant D, Friisk GA, Skotland T. Metabolism of mangafodipir trisodium (MnDPDP), a new contrast medium for magnetic resonance imaging, in beagle dogs. Eur J. Drug Metab. Pharmacokinet. 1997; 22: 65-72.
66. Gallez B, Bacie G, Swartz HM. Evidence for the dissociation of the hepatobiliary MRI contrast agent Mn-DPDP. Magn. Reson. Med. 1996; 35: 14-19.
67. Schmidt PP, Toft KG, Skotland T, Andersson K. Stability and transmetallation of the magnetic resonance contrast agent MnDPDP measured by EPR. J. Biol. Inorg. Chem. 2002; 7: 241-248.
68. 2. Acta Radiol. 1997; 38: 700-707.
69. Berridge MJ, Bootman P, Lipp P. Calcium - a life and death signal. Nature 1998; 395: 645-648.
70. Demaurex N, Distelhorst C. Apoptosis-the calcium connection. Science 2003; 300: 65-67.
71. Nasu T. Actions of manganese ions in contraction of smooth muscle. Gen. Pharmac. 1995; 26: 945-953.
72. Marchal G, Ni Y, Herijgers P, Flameng W, Petre C, Bosmans H, Yu J, Ebert W, Hilger CS, Pfefferer D, Semmler W, Baert AL. Paramagnetic metalloporphyrins: infarct avid contrast agents for diagnosis of acute myocardial infarction by MRI. Eur. Radiol. 1996; 6: 2-8.
73. Ni Y, Petre C, Miao Y, Yu J, Cresens E, Adriaens P, Bosmans H, Semmler W, Baert AL, Marchal G. Magnetic resonance imaging-histomorphologic correlation studies on paramagnetic metalloporphyrins in rat models of necrosis. Invest. Radiol. 1997; 32: 770-779.
74. Arheden H, Saced M, Higgins CB, Gao DW, Ursell PC, Bremerich J, Wyttenbach R, Dae MW, Wendland MF. Reperfused rat myocardium subjected to various durations of ischemia: estimation of the distribution volume of contrast material with echo-planar MR imaging. Radiology 2000; 215: 520-528.
75. Bremerich J, Wendland MF, Arheden H, Wyttenbach R, Gao DW, Huberty JP, Dae MW, Higgins CB, Saeed M. Microvascular injury in reperfused infarcted myocardium: noninvasive assessment with contrast-enhanced echoplanar magnetic resonance imaging. J. Am. Coll. Cardiol. 1998; 32: 787-793.
76. Simonetti OP, Kim RJ, Fieno DS, Hillenbrand HB, Wu E, Bundy JM, Finn JP, Judd RM. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001; 218: 215-223.
77. Judd RM, Kim RJ. Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging. Circulation 2002; 106: e6.
78. Lima JA, Judd RM, Bazille A, Schulman SP, Atalar E, Zerhouni EA. Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. Circulation 1995; 92: 1117-1125.
79. Rochite CE, Lima JAC, Bluemke DA, Reeder SB, McVeigh ER, Furuta T, Becker LC, Melin JA. Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction. Circulation 1998; 98: 1006-1014.
80. Saeed M, Wendland MF, Bremerich GL, Weinmann HJ, Higgins CB. Assessment of myocardial viability using standard extracellular and necrosis specific MR contrast media. Acad. Radiol. 2002; 9: S84-S87.
81. Oshinski JN, Yang Z, Jones JR, Mata JF, Franch BF. Imaging time after GdDTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging. Circulation 2001; 104: 2838-2842.
82. Harnish P, Seoane P, Vessey A. Manganese compositions and methods for MRI. US patent no. 5980863, 1999.
83. Abolmaali ND, Schmitt J, Schick C, Vogl TJ. Manganese enhanced imaging of the healthy myocardium and myocardium in chronic heart failure: preliminary results. Eur. Radiol. 2003; 13 Supp.): 305.